Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
Clinical trial NCT03755778 · COMPLETED
Trial details
- NCT number
- NCT03755778
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2019-01-21
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.